Board Games Among Mild Cognitive Impairment Patients Experience (GAME Project) (GAME-Project)

April 6, 2021 updated by: jaume march llanes, Brain In Game scientific-technical service

Effectiveness on Cognition of a Cognitive Training Intervention Based on Modern Board and Card Games in Mild Cognitive Impairment Patients: a Randomized Controlled Trial

Nowadays, on geriatric centres, cognitive decline used to be prevented by pen and paper exercises (Calero García & Navarro Gonzalez, 2006). However, as Lampit et al. (2014) suggest, studies based on the efficacy and effectiveness of new cognitive-based interventions in order to improve these cognitive processes are fundamental (Lampit et al., 2014). Cognitive-based interventions are interventions that directly or indirectly try to improve cognitive processes (Chiu et al., 2017). Between the different kinds of cognitive-based interventions, cognitive training permits stablish randomized controlled trials. Cognitive training consists of repeating during a concrete time a standardized set of tasks in order to maintain or improve one or some cognitive processes. Meta-analysis studies have shown that computerized cognitive training can improve in a moderate size some cognitive processes in elderly people with mild cognitive impairment or dementia (Hill et al., 2017) and without those diagnoses (Lampit, Hallock, & Valenzuela, 2014; Chiu et al., 2017). Although it seems that computerized training is effective, safe and secure, it is important to note the social component of the definition of health (OMS, 1948). Chang, Wray & Lin (2014) found that social relationships predict the use of leisure activities and this predict a better physical health and wellbeing psychological. In fact, a comparative study found that those elderly people that have played board games have a 15% lower risk of having dementia diagnose and problems related with memory (Dartigues et al., 2013). To sum up, the aim of this research project is to test the effectiveness of a cognitive training based on modern board and card games in elderly people with a diagnose of mild-cognitive impairment in comparison to do cognitive paper and pencil tasks or in a wait-list comparison group.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lleida, Spain, 25001
        • Recruiting
        • Faculty of Education, Psychology and Social Work; University of Lleida
        • Contact:
        • Principal Investigator:
          • Jaume March-Llanes, PhD
        • Sub-Investigator:
          • Verónica Estrada-Plana, MsC
      • Lleida, Spain, 25198
        • Recruiting
        • Cognitive disorders unity, Santa Maria's University Hospital, GSS
        • Contact:
          • Beatriu Lara Consuegra, MsC
          • Phone Number: 1571 +34 972727222
          • Email: blara@gss.cat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participation in cognitive disease center
  • Amnestic MCI diagnoses (clinical diagnoses following the guidelines of Petersen et al. 2011)
  • Global deterioration scale (GDS) 2-3 values
  • Participation assessing outcomes of the caregivers in the study

Exclusion Criteria:

  • Participation in another cognitive training program
  • Dementia, neurologic or other disease non-neurodegenerative, which could affect cognitive change over time (medical-reported)
  • Severe visual impairment, language impairment or motoric impairment of the upper extremity which significantly affects ability to solve jigsaw puzzles (medical-reported)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral: modern board and card games
Participants will play modern board and card games in groups at medical center 2 times per week for at least 1 hour over a period of 16 weeks.
Modern board and card games group
Active Comparator: Behavioral: paper and pencil tasks
Participants will do cognitive paper and pencil tasks in groups at medical center 2 times per week for at least 1 hour over a period of 16 weeks.
Paper and pencil tasks group
No Intervention: Wait-list
Participants will be in a wait-list over a period of 16 weeks. Then, they received the board and card games' or paper and pencil tasks' intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cognitive impairment from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Addenbrooke's Cognitive Examination
Baseline and post intervention (after 16 weeks)
Change in visuoconstruction, immediate memory and long-term memory from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Copy, draw after 3 and after 25 minuts of Rey-Osterrieth Complex Figure Test
Baseline and post intervention (after 16 weeks)
Change in verbal long-term memory from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Rey Auditory Verbal Learning Test (RAVLT)
Baseline and post intervention (after 16 weeks)
Change in verbal short-term memory from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Digit Memory Test Forward
Baseline and post intervention (after 16 weeks)
Change in verbal working memory from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Digit Memory Test Backward
Baseline and post intervention (after 16 weeks)
Change in visuospatial short-term memory from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Visual Memory Test Forward
Baseline and post intervention (after 16 weeks)
Change in visuospatial working memory from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Visual Memory Test Backward
Baseline and post intervention (after 16 weeks)
Change in visuospatial processing from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Trail Making Test A and Symbol Digit Modalities Test (SDMT)
Baseline and post intervention (after 16 weeks)
Change in flexibility from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Trail Making Test B and 5 digits test
Baseline and post intervention (after 16 weeks)
Change in inhibition from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
5 digits test
Baseline and post intervention (after 16 weeks)
Change in phonemic and semantic fluency from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Animals category and P, M, R letters, Spanish version
Baseline and post intervention (after 16 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in neuropsychiatric symptoms from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Neuropsychiatric Inventory (NPI), Self-reported and caregivers spanish versions. Higher scores mean higher neuropsychiatric symptomatology.
Baseline and post intervention (after 16 weeks)
Change in psychological well-being from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Euro Quality of Life Scale (EQ-5D), Self-reported and caregivers spanish versions. Higher scores mean higher quality of life. Visual analogue scale: minimum value=0, maximum value=100.
Baseline and post intervention (after 16 weeks)
Change in depressive symptoms from baseline to post intervention
Time Frame: Baseline and post intervention (after 16 weeks)
Geriatric Depression Scale (GDS), Spanish version. Higher scores mean higher depressive symptomatology. Minimum value = 0, maximum value = 15.
Baseline and post intervention (after 16 weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Status Index and sociodemographical information
Time Frame: Baseline
Hollingshead Index, age, sex, birth location
Baseline
Cognitive reserve questionnaire
Time Frame: Baseline
Cognitive reserve questionnaire (CRC), spanish version
Baseline
Premorbid cognitive function
Time Frame: Baseline
The Word Accentuation Test (TAP), spanish version
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2021

Primary Completion (Anticipated)

March 1, 2024

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

March 22, 2021

First Submitted That Met QC Criteria

April 6, 2021

First Posted (Actual)

April 8, 2021

Study Record Updates

Last Update Posted (Actual)

April 8, 2021

Last Update Submitted That Met QC Criteria

April 6, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment, Mild

Clinical Trials on Modern board and card games group

Subscribe